Evidence to date suggests that the risk for all-cause dementia is 40% to 60% higher in patients with type 1 or type 2 diabetes.
Primary care diabetes prevention programs that promote physical activity become less effective when patients experience depressive symptoms.
Guidelines address lifestyle recommendations, individualized BP targets, SGLT2 inhibitor, GLP1-RA treatment.
Review indicates little to no effect on newly diagnosed diabetes, measures of glucose metabolism.
The FDA has granted 510(k) market clearance to the OneDraw A1C Test system, which monitors HbA1c levels in individuals with diabetes for long-term glucose control.
Analysis of 11 websites shows poor quality, varying accuracy, low readability.
The AACE has produced a position statement addressing population-specific challenges and practical steps for clinicians with regard to diabetes care for African Americans, Latinx/Hispanics, Asian Americans, and Native Americans.
Risk significantly higher for patients receiving diagnosis of IBD from 2003 through 2014 vs earlier.
For individuals younger than 65, stroke risk increased for white women and men, black women, but not black men.
Patients with T2D and obesity who monitored their blood glucose more frequently had better outcomes after a 12-week intensive weight management program.
Lifestyle management should be priority for prevention of ASCVD, T2DM in patients at metabolic risk.
In women with HIV and diabetes mellitus, CD4+ lymphocytes may contribute to the development of diabetes mellitus.
Med-EatPlan plus extra virgin olive oil linked to lower risk for starting first glucose-lowering medication.
Greater variability tied to higher risk, independent of mean levels for BMI, HDL cholesterol in childhood.
The Endocrine Society published a clinical practice guideline cosponsored by the American Diabetes Association and the European Society of Endocrinology regarding the primary prevention of ASCVD and T2D.
Findings seen in propensity-matched cohorts vs receipt of DPP-4 inhibitors or GLP-1 agonists.
Benefits on peripheral insulin sensitivity, disposition index for those at-risk or newly-diagnosed with T2DM.
Continuous increase in risk of pancreatic cancer with elevating fasting glucose, even within normal range.
Individual session attendance more strongly tied to weight loss in Hispanics, African-Americans.
Targeted screening should be considered in high-risk patients following H pylori eradication therapy.